A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)
Clinical trial NCT00127127 · COMPLETED
Trial details
- NCT number
- NCT00127127
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-10
- Primary completion
- 2009-08-21
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.